TrialJournal of cancer research and clinical oncology2019

Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.

Laura Budau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.